HK Stock Connect Daily Report: Biotech Stocks Shine; FTSE China 50 Adds Hua Hong Grace and Montage Technology - 20260902

NewTimeSpace · 2026/09/02 19:10 · By Xuran Lin

On September 2, Hong Kong's three major indices declined across the board, with the Hang Seng Index edging down 0.07% to 25,311.21 points and the Hang Seng TECH Index falling 0.74%, on turnover of HKD 216.691 billion. Biotech stocks stood out, with Biocytogen up 11.52% and Simcere Pharma up 7.64% after the company signed a global licensing agreement with Roche worth more than USD 1.53 billion. Auto stocks were broadly under pressure, with Li Auto hitting a new low since its Hong Kong listing. Southbound capital recorded net buying of HKD 4.093 billion. In the quarterly review of the FTSE China 50 Index, Hua Hong Grace and Montage Tech were added, effective September 18; NIO's second-quarter revenue rose 69% year on year; and Haichang Ocean Park will be removed from Stock Connect from September 7.

I. Market Overview

On September 2, Hong Kong's three major indices declined across the board: the Hang Seng Index edged down 0.07% to 25,311.21 points, the Hang Seng TECH Index fell 0.74% and the Hang Seng China Enterprises Index shed 0.15%. Full-day turnover reached HKD 216.691 billion, contracting further from the previous trading day.

Biotech and pharmaceutical stocks stood out during the session: Biocytogen-B (02315) rose 11.52%, CStone Pharma-B (02616) gained 8.33% and Zai Lab (09688) added 5.45%. The property sector firmed, with China Overseas (00688) up 4.55% while Longfor Group fell 4.4%, showing divergence within the sector. Auto stocks were broadly under pressure: Li Auto-W (02015) hit a new low since its Hong Kong listing and XPeng-W (09868) fell 2.34%, with new-energy vehicle startups delivering divergent performance after August delivery figures were released. Non-ferrous metals traded weakly, with Zijin Mining (02899) down 1.7%. Power equipment stocks, PCB-related names and airline stocks also declined.

Southbound capital recorded net buying of HKD 4.093 billion on the day, of which the Shanghai leg of Stock Connect posted net buying of HKD 5.763 billion and the Shenzhen leg net selling of HKD 1.67 billion.

II. HK Stock Connect Stock Rankings

2.1 HK Stock Connect Stock Gainers and Decliners

Category	Stock Code	Stock Name	Change (%)	Close (HKD)	Turnover (HKD 100mn)
Top Gainer 1	01686.HK	SUNEVISION	15.34	5.64	2.08
Top Gainer 2	02687.HK	ABLE DIGITAL	11.68	321.20	0.72
Top Gainer 3	02315.HK	BIOCYTOGEN-B	11.52	63.90	2.09
Top Gainer 4	02096.HK	SIMCERE PHARMA	7.64	11.83	1.71
Top Gainer 5	00668.HK	ANKER	6.73	134.80	1.26
Top Decliner 5	03939.HK	WANGUO GOLD GP	-7.13	14.72	10.92
Top Decliner 4	02652.HK	CF PHARMTECH	-7.97	12.70	0.24
Top Decliner 3	00268.HK	KINGDEE INT'L	-8.03	8.13	4.47
Top Decliner 2	09678.HK	UNISOUND	-9.14	77.55	3.01
Top Decliner 1	02718.HK	MININGLAMP-W	-9.23	49.20	2.79

Source: Wind, HKEX. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

2.2 HK Stock Connect Active Stocks (ranked by southbound turnover)

Rank	Stock Code	Stock Name	Southbound Turnover (HKD 100mn)	Southbound Net Buy (HKD 100mn)	Change (%)
1	00700.HK	TENCENT	57.00	3.36	-0.72
2	06869.HK	YOFC	39.76	2.88	3.23
3	00100.HK	MINIMAX-W	29.38	3.35	1.72
4	02513.HK	Z.AI	27.11	3.17	-5.26
5	09988.HK	ALIBABA-W	25.91	-7.65	-0.45
6	03690.HK	MEITUAN-W	20.34	0.99	2.74
7	01888.HK	KB LAMINATES	19.49	-1.55	3.29
8	00981.HK	SMIC	15.96	-2.62	-0.87
9	01299.HK	AIA	10.21	9.66	0.07
10	03308.HK	ZJ INNOLIGHT	8.82	4.52	0.19

III. HK Stock Connect-related A-share ETF Rankings

3.1 HK Stock Connect-related A-share ETF Gainers and Decliners

Category	Code	Short Name	Change (%)	Turnover (RMB 100mn)
Top Gainer 1	159297	China Southern CNI HK Equities Innovative Drugs ETF	0.55	3.79
Top Gainer 2	520880	Hwabao WP Hang Seng HK Innovative Drugs Selected ETF	0.44	2.97
Top Gainer 3	159567	Yinhua CNI HK Equities Innovative Drugs ETF	0.43	7.01
Top Gainer 4	520690	Bosera Hang Seng HK Innovative Drugs Selected ETF	0.41	0.86
Top Gainer 5	159217	ICBCCS CNI HK Equities Innovative Drugs ETF	0.34	3.79
Top Decliner 5	520600	GF CSI HK Equities Vehicles Industry Theme ETF	-2.87	1.61
Top Decliner 4	159028	Tianhong Hang Seng HK Equities Automobile Theme ETF	-3.01	0.12
Top Decliner 3	520780	Hwabao WP CSI HK Equities Vehicles Industry Theme ETF	-3.06	0.13
Top Decliner 2	520680	China Southern CSI HK Equities Vehicles Industry Theme ETF	-3.20	0.07
Top Decliner 1	159210	China Universal CSI HK Equities Vehicles Industry Theme ETF	-3.26	0.19

Source: Wind. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

3.2 HK Stock Connect-related A-share ETF Active Rankings (ranked by turnover)

Rank	Code	Short Name	Tracking Index	Turnover (RMB 100mn)	Turnover Rate (%)	Change (%)
1	159570	China Universal CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	21.94	9.70	0.28
2	159792	Fullgoal CSI HK Equities Internet ETF	CSI HK Equities Internet Index	12.37	3.42	-1.05
3	159131	Hwabao CSI HK Equities Information Technology Integration ETF	CSI HK Equities Information Technology Integration Index (HKD)	11.33	51.66	-1.22
4	159567	Yinhua CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	7.01	9.72	0.43
5	159316	E Fund Hang Seng HK Innovative Drugs ETF	Hang Seng HK Innovative Drugs Index	5.73	9.41	0.26
6	513190	ChinaAMC CSI HK Equities Interior Finance ETF	CSI HK Equities Interior Finance Index (HKD)	5.34	28.67	-0.95
7	526000	ChinaAMC CSI HK Equities Information Technology Integration ETF	CSI HK Equities Information Technology Integration Index (HKD)	5.04	240.31	-1.40
8	513780	Invesco Great Wall CSI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	4.95	15.66	0.12
9	513750	GF CSI HK Connect Financials (ex Banks) Thematic ETF	CSI HK Connect Financials (ex Banks) Thematic Index (RMB)	4.68	3.72	-1.78
10	159506	Fullgoal Hang Seng HK Equities Innovative Drugs And Health Care ETF	Hang Seng HK Equities Innovative Drugs And Health Care Index	4.60	13.86	0.23

IV. Industry and Corporate Updates

1. FTSE China 50 Quarterly Review: Hua Hong Grace and Montage Tech Added, Kuaishou-W and SF Holding Removed, Effective September 18

On September 2, FTSE Russell announced quarterly review changes to the FTSE China Index Series. FTSE China 50 will add Hua Hong Grace (01347.HK) and Montage Tech (06809.HK), and remove Kuaishou-W (01024.HK) and SF Holding (06936.HK); the changes will take effect after the market close on September 18. FTSE China 50 also released its reserve list for the new quarter, which includes China Coal Energy (01898.HK), CSC (06066.HK), Lens Technology (06613.HK), WuXi Biologics (02269.HK) and Yankuang Energy (01171.HK) among other Hong Kong-listed names. Hua Hong Grace and Montage Tech are both Stock Connect constituents.

2. NIO-SW Second-Quarter Revenue RMB 32.137 Billion, Up 69.1% Year on Year

On September 1, NIO-SW (09866.HK) reported its 2026 second-quarter results, with volume and price rising across its three brands. Total revenue reached RMB 32.137 billion in the quarter, up 69.1% year on year and 25.9% quarter on quarter; vehicle sales revenue stood at RMB 29.058 billion; adjusted net profit was RMB 26.1 million; the net loss narrowed sharply year on year to RMB 228 million; the gross margin was 18.4%; and the company held RMB 56.7 billion in cash. NIO is a potential Stock Connect constituent.

3. RiboLife-B Turned Profitable at the Interim as Revenue Surged 304%

On August 27, RiboLife-B (06938.HK) disclosed its 2026 interim results: revenue of RMB 420 million, up 304% year on year; net profit attributable to shareholders of RMB 20.3 million, swinging to a profit year on year; and cash and cash equivalents of RMB 2.24 billion at the end of the period. RiboLife was added to the Hang Seng Composite Index on August 21 and is expected to become a Stock Connect constituent.

4. Medcaptain's Public Offering Closed Today, Oversubscribed over 437 Times; Trading Expected to Commence September 7

On September 2, the public offering of Medcaptain (02041.HK), a medical device provider, closed at noon. According to reports, the public tranche drew preliminary subscriptions of 437.78 times, attracting around 58,000 applicants. The company plans a global offering of 38,910,600 H shares at an offer price of HK$15.42 per share, with a board lot of 100 shares and an application fee of about HK$1,557.55. Trading is expected to commence on September 7.

5. Haichang Ocean Park's First-Half Loss Widened; to Be Removed from Stock Connect from September 7

On September 2, Haichang Ocean Park (02255.HK) fell nearly 5% intraday, touching HK$0.213, a new low in more than five and a half years. The company's 2026 interim results showed first-half revenue of RMB 536 million, down 21.91% year on year, and a loss attributable to shareholders of RMB 332 million, widening 12.66% year on year. Under the Hang Seng Indexes Company's semi-annual index review, Haichang Ocean Park has been removed from the Hang Seng Composite Index; the change will be implemented after the close on September 4 and take effect from September 7, when the stock will also be dropped from Stock Connect.

V. Market Notes

Eligible securities list adjustment announcement

No recent announcements.

Trading calendar

No approaching market closure days.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

HK Stock Connect Daily Report SUNEVISION Tencent China Southern CNI HK Equities Innovative Drugs ETF China Universal CNI HK Equities Innovative Drugs ETF